Markus Klotz
Advancing apheresis-led protocols for recovery, resilience and longevity
Markus Klotz is a Swiss researcher and specialist in therapeutic apheresis, and Co-Founder, Research & Med Tech at Elysium Institut in Zürich. His work focuses on advanced extracorporeal med tech therapies and individualised multimodal protocols for complex chronic conditions, with attention to microcirculation, immune modulation and post-viral inflammatory states.
After recovering from severe Long COVID with H.E.L.P. Apheresis and Multimodal Combination Therapy under Dr Beate Jaeger in Germany, Markus helped establish the Apheresis Center Larnaca in February 2022, where he is described as managing director and head of research. He is also listed as a member of the RAPID research team and has contributed to expert discussions on immune, mitochondrial and clotting factors in Long COVID.
At Copenhagen Health Week, he brings a practical perspective on how precision diagnostics, therapeutic apheresis and regenerative medicine can come together in patient-focused longevity care.
